Target intelligence / Profile preview

T-complex protein 1 subunit delta (CCT4)

Target
CCT4
Molecular classification
Molecular chaperone, Heat shock protein family, Chaperonin (Group II chaperonin/TRiC/CCT complex)
01

Overview

T-complex protein 1 subunit delta (CCT4) is one of the eight distinct subunits that compose the eukaryotic chaperonin-containing TCP1 complex (also known as TRiC or CCT), a molecular chaperone complex essential for ATP-dependent folding of newly synthesized proteins such as actin and tubulin[1][2][5]. CCT4 helps maintain cellular proteostasis and architecture by promoting efficient protein folding, and forms part of large oligomeric double-ring structures, either as a hetero-oligomer within the CCT complex or as homo-oligomers capable of chaperone activity[1][5]. Beyond general protein quality control, CCT4 is linked to specific pathophysiological contexts including neurodegeneration and several cancer types, where altered expression or function contributes to disease mechanisms (notably, promoting tumor growth via mTOR pathway activation in glioblastoma)[1]. Targeting CCT4 pharmacologically is considered challenging due to the fundamental nature of its biological role.

Other names
Chaperonin containing TCP1 subunit 4CCTDSRBTCP-1-deltaCctdCCT-deltaStimulator of TAR RNA-bindingCCT-DELTAChaperonin containing T-complex polypeptide 1 subunit 4chaperonin containing TCP1, subunit 4 (delta)chaperonin containing t-complex polypeptide 1, delta subunit
02

Mechanism of action

Modulation of protein folding capacity Potential modulation of mTOR pathway activity via involvement in chaperoning mLST8 in glioblastoma

03

Biological functions

Protein foldingProtein quality controlCellular architecture maintenanceCellular proteostasisAssistance in cytoskeletal protein folding (e.g., actin, tubulin)
04

Disease associations

CancerNeurodegenerative diseaseHereditary sensory neuropathy
05

Safety considerations

Potential therapeutic challenges due to essential role in protein homeostasis and folding of multiple cellular proteinsRisk of toxicity when targeting essential chaperone function in non-cancerous cells
06

Biomarkers

Deregulated expression in cancer (e.g., glioblastoma, esophageal squamous cell carcinoma)

Beyond the preview

Go deeper on T-complex protein 1 subunit delta (CCT4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-complex protein 1 subunit delta (CCT4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call